Taubman Institute-Israel Initiative
The Taubman Institute has launched an initiative to establish collaborations between leading medical researchers in Michigan and their colleagues in Israel. The impetus behind the effort came from a trip to medical research facilities in Israel that Alfred Taubman took in 2008 with Institute Director Eva Feldman, M.D., Ph.D., and Institute Co-Chair Gayle Taubman Kalisman, Ed.D.
“We were very impressed by the ground-breaking research being done in Israel,” said Alfred Taubman. “And we immediately recognized the opportunities for collaboration between U of M and the talented scientists in Israel.”
To encourage the exchange of medical knowledge, the Institute has held two A. Alfred Taubman Lectureships at the University of Michigan, presented by preeminent Israeli stem cell researchers:
- Miguel Weil, Ph.D., profession of life sciences at Tel Aviv University spoke on September 17, 2008. The title of his talk was “Mesenchymal Stem Cells in Regenerative Medicine.”
- Benjamin Reubinoff, M.D., Ph.D., professor of neurology at Hadassah Medical Center presented his lecture on January 2009. One of the world’s pioneers in embryonic stem cell science, he spoke on the topic: “Human Embryonic Stem Cells: A Promising Therapy for Neurological Disorders.”
Both lectures were very well attended by U-M researchers. Preceding the talks, a reception was held for members of the University of Michigan and local Jewish communities. In addition, following Dr. Reubinoff’s lecture, the Greater Detroit Chapter of Hadassah sponsored a luncheon in his honor.
The Taubman Institute will continue to build relationships and joint projects with eminent Israeli scientists.
Stem cell symposium set for Sept. 19 in Ann Arbor
Dr. Eva Feldman will be among the speakers at the one-day event, which focuses on cutting-edge developments in stem-cell biology, epigenetics and regneratrive medicine.
Click here for details and registration.
New U-M President visits Taubman Institute
The Institute hosted a fellow clinician-scientist when the University of Michigan’s new president paid a visit to the A. Alfred Taubman Biomedical Science Research Building.
People who care
Institute welcomes new gift officer
Maria Muller has been appointed to work with connect donors with funding opportunities at the Taubman Institute.
Click here to read more.
news & events
Institute symposium set for Oct. 10
The A. Alfred Taubman Medical Research Institute will award the 2014 $100,000 Taubman Prize for Excellence in Translational Medical Science at its 7th annual symposium at 10 a.m. on Oct. 10.
Dr. Carl June, a physician-scientist who developed a personalized immunotherapy for leukemia using patients’ own T cells, will receive the honor and deliver the symposium's keynote address.
Click here for symposium details.
Drug cuts risk of bone-marrow transplant side effect
Taubman Emerging Scholar Sung Won Choi, M.D., is the lead author of a new study that finds a new way to help prevent graft-vs-host disease in cancer patients receiving bone-marrow transplants.
Study: Two types of cancer stem cells lead to metastasis
Breast cancer stem cells exist in two different states and each state plays a role in how cancer spreads, according to a new study published by Taubman Senior Scholar Dr. Max Wicha.